APA (7th ed.) Citation

Shin, J., Kim, H., Yim, H. W., Kim, J. H., Lee, S., & Kim, H. (2022). Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use. Journal of Clinical Pharmacy & Therapeutics, 47(1), 97. https://doi.org/10.1111/jcpt.13544

Chicago Style (17th ed.) Citation

Shin, Juyoung, Hyunah Kim, Hyeon Woo Yim, Ju Han Kim, Suehyun Lee, and Hun‐Sung Kim. "Angiotensin‐converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers: New‐onset Diabetes Mellitus Stratified by Statin Use." Journal of Clinical Pharmacy & Therapeutics 47, no. 1 (2022): 97. https://doi.org/10.1111/jcpt.13544.

MLA (9th ed.) Citation

Shin, Juyoung, et al. "Angiotensin‐converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers: New‐onset Diabetes Mellitus Stratified by Statin Use." Journal of Clinical Pharmacy & Therapeutics, vol. 47, no. 1, 2022, p. 97, https://doi.org/10.1111/jcpt.13544.